Arch Acad Emerg Med. 2020 Jun 07;8(1):e62. eCollection 2020.
Central Nervous System Complications in COVID-19 Patients; a Systematic Review and Meta-Analysis based on Current Evidence.
Archives of academic emergency medicine
Arian MadaniNeishaboori, Donya Moshrefiaraghi, Kosar Mohamed Ali, Amirmohammad Toloui, Mahmoud Yousefifard, Mostafa Hosseini
Affiliations
Affiliations
- Physiology Research Center, Iran University of Medical Sciences, Tehran, Iran.
- College of Medicine, University of Sulaimani, Sulaimani, Iraq.
- Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
PMID: 33134959
PMCID: PMC7587989
Abstract
INTRODUCTION: Several studies have confirmed neurological involvements, such as acute cerebrovascular disease and impaired consciousness in COVID-19. In the present study, our aim is to investigate the current evidence regarding central nervous system (CNS) complications in patients with confirmed COVID-19.
METHODS: An extensive search was conducted in electronic databases including Medline (using PubMed), Embase, Scopus, and Web of Science, in addition to the manual search in Google and Google scholar search engines, for articles published from 2019 until April 21st, 2020. Inclusion criteria was articles that were reviewed and reported the incidence of neurological outcomes in patients with confirmed COVID-19 disease.
RESULTS: The initial search yielded 638 records, from which 7 articles were included. Overall, the incidence of CNS complications was calculated to be 6.27% (95% CI: 3.32 to 9.98). The incidence of the most common CNS complications, encephalopathy and acute cerebrovascular disease, were 9.14% (95%CI: 2.20 to 19.81) and 2.59% (95% CI: 1.31 to 4.25), respectively.
CONCLUSION: CNS complications do exist in COVID-19 patients, encephalopathy being the most concerning one. The heterogeneity in the existing literature causes an uncertainty in reporting the definite prevalence rate for each complication. Thus, further studies are needed for scientists to reach a more accurate estimate of the prevalence of these complications in COVID-19 patients. However, healthcare providers should consider the possibility of CNS involvements in patients with SARS-CoV-2 infection.
Keywords: COVID-19; Central Nervous System Diseases; Prevalence; Stroke
References
- Lancet. 2020 Feb 15;395(10223):514-523 - PubMed
- Lancet. 2020 Feb 22;395(10224):565-574 - PubMed
- Lancet. 2020 Feb 15;395(10223):470-473 - PubMed
- JAMA. 2020 Mar 17;323(11):1061-1069 - PubMed
- N Engl J Med. 2020 Apr 30;382(18):1708-1720 - PubMed
- ACS Chem Neurosci. 2020 Apr 1;11(7):995-998 - PubMed
- Am J Respir Crit Care Med. 2019 Oct 1;200(7):e45-e67 - PubMed
- J Virol. 2020 Mar 17;94(7): - PubMed
- Thromb Res. 2020 Jul;191:9-14 - PubMed
- BMJ. 2020 Mar 26;368:m1091 - PubMed
- N Engl J Med. 2020 Jun 4;382(23):2268-2270 - PubMed
- Int J Infect Dis. 2020 May;94:55-58 - PubMed
- Thromb Res. 2020 Jul;191:145-147 - PubMed
- Eur Respir J. 2020 May 14;55(5): - PubMed
- Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Jun 24;48(6):456-460 - PubMed
- Intervirology. 2016;59(3):163-169 - PubMed
- JAMA Neurol. 2020 Jun 1;77(6):683-690 - PubMed
- Epilepsia. 2020 Jun;61(6):e49-e53 - PubMed
- N Engl J Med. 2020 Feb 20;382(8):727-733 - PubMed
- J Med Virol. 2020 Jul;92(7):705-706 - PubMed
- J Virol. 2008 Aug;82(15):7264-75 - PubMed
- Lancet. 2020 Mar 28;395(10229):1054-1062 - PubMed
- Stroke Vasc Neurol. 2020 Sep;5(3):279-284 - PubMed
- Cureus. 2020 Mar 21;12(3):e7352 - PubMed
- Lancet. 2020 Feb 15;395(10223):497-506 - PubMed
- Brain Behav Immun. 2020 Jul;87:18-22 - PubMed
Publication Types